Unveiling six potent and highly selective antileishmanial agents via the open source compound collection ‘Pathogen Box’ against antimony-sensitive and -resistant Leishmania braziliensis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unveiling six potent and highly selective antileishmanial agents via the open source compound collection ‘Pathogen Box’ against antimony-sensitive and -resistant Leishmania braziliensis
Authors
Keywords
Leishmania braziliensis, Pathogen box, MMV, CRK3, CYP450, PKA
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 133, Issue -, Pages 111049
Publisher
Elsevier BV
Online
2020-12-04
DOI
10.1016/j.biopha.2020.111049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis
- (2020) Awanish Kumar et al. PARASITE IMMUNOLOGY
- Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
- (2020) Markos Tadele et al. Drug Design Development and Therapy
- Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani
- (2020) Wandayi Emmanuel Amlabu et al. PLoS Neglected Tropical Diseases
- Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors
- (2020) Luiza G. Tunes et al. ACS Infectious Diseases
- An Antiparasitic Compound from the Medicines for Malaria Venture Pathogen Box Promotes Leishmania Tubulin Polymerization
- (2020) Imran Ullah et al. ACS Infectious Diseases
- Unpacking the Pathogen Box
- (2019) Clinton Veale ChemMedChem
- Identification of potential inhibitors targeted for strengthening search of anti-leishmanial therapeutics
- (2019) Anubhuti Jha et al. BIOLOGIA
- Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays
- (2018) Sarah L. Berry et al. PLoS Neglected Tropical Diseases
- Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions
- (2018) Jeronimo N. Rugani et al. BIOMEDICINE & PHARMACOTHERAPY
- In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum
- (2017) Joachim Müller et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures
- (2017) Harry C Jubb et al. JOURNAL OF MOLECULAR BIOLOGY
- Chemotherapy of leishmaniasis: present challenges
- (2017) SILVIA R. B. ULIANA et al. PARASITOLOGY
- A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
- (2017) Ebere Sonoiki et al. Nature Communications
- Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening
- (2017) Diana Ortiz et al. PLoS Neglected Tropical Diseases
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes
- (2016) Mozna Khraiwesh et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors
- (2016) Taissa Vila et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor
- (2016) Ana L. Valenciano et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
- (2016) Daniel Stoessel et al. Metabolomics
- CSM-lig: a web server for assessing and comparing protein–small molecule affinities
- (2016) Douglas E.V. Pires et al. NUCLEIC ACIDS RESEARCH
- A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome
- (2016) Adriano C. Coelho et al. PLoS Neglected Tropical Diseases
- The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
- (2016) Stephen Patterson et al. eLife
- Screening of the ‘Pathogen Box’ identifies an approved pesticide with major anthelmintic activity against the barber's pole worm
- (2016) Sarah Preston et al. International Journal for Parasitology-Drugs and Drug Resistance
- In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs
- (2015) Qaisar Jamal et al. EXPERIMENTAL PARASITOLOGY
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pyridyl Benzamides as a Novel Class of Potent Inhibitors for the Kinetoplastid Trypanosoma brucei
- (2014) Lori Ferrins et al. JOURNAL OF MEDICINAL CHEMISTRY
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- Identification of novel candidate compounds targeting TrkB to induce apoptosis in neuroblastoma
- (2014) Yohko Nakamura et al. Cancer Medicine
- Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
- (2013) Manu De Rycker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chemical probes of a trisubstituted pyrrole to identify its protein target(s) in Plasmodium sporozoites
- (2013) Tyrell Towle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Molecular Basis of Differential Selectivity of Cyclobutyl-Substituted Imidazole Inhibitors against CDKs: Insights for Rational Drug Design
- (2013) Soumya Lipsa Rath et al. PLoS One
- Target specific-trisubstituted pyrrole inhibits Babesia bovis erythrocytic growth
- (2012) Audrey O.T. Lau et al. EXPERIMENTAL PARASITOLOGY
- Open Source Drug Discovery in Practice: A Case Study
- (2012) Christine Årdal et al. PLoS Neglected Tropical Diseases
- An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
- (2012) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis
- (2011) Robert T Jacobs et al. Future Medicinal Chemistry
- CYP5122A1, a Novel Cytochrome P450 Is Essential for Survival of Leishmania donovani
- (2011) Smriti Verma et al. PLoS One
- Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis
- (2010) B. Nare et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phospholipid and sphingolipid metabolism in Leishmania
- (2009) Kai Zhang et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Detection of multiscale pockets on protein surfaces using mathematical morphology
- (2009) Takeshi Kawabata PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions
- (2009) Peter Ertl et al. Journal of Cheminformatics
- Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors
- (2008) Clifford D. Jones et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started